bortezomib
Bortezomib is a drug used to treat Multiple Myeloma, Lymphoma, Mantle Cell Lymphoma, and other conditions. Bortezomib is being actively studied in 122 studies and prior, has been studied in 317.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| National Cancer Institute (NCI) | Mayo Clinic | Irene Ghobrial, MD |
| Dana-Farber Cancer Institute | Dana-Farber Cancer Institute | Paul G. Richardson, MD |
| M.D. Anderson Cancer Center | Washington University School of Medicine | E. Steve Woodle |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
- Lymphoma, Mantle Cell
- Mantle Cell Lymphoma
- Rituximab (R)
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2021-09-21
Sep 21, 2021M
M
E
Active, not recruiting
- Multiple Myeloma
- Bortezomib
- Dexamethasone
- Rionero in Vulture, Potenza, ItalyIrccs Crob
2021-02-04
Feb 4, 2021N
Completed
- Lung Diseases, Interstitial
- +2 more
- Bortezomib
- +2 more
- Chicago, IllinoisNorthwestern University
2021-08-02
Aug 2, 2021M
Completed
- Relapsed or Refractory Multiple Myeloma
- Vorinostat
- +2 more
- (no location specified)
2021-03-05
Mar 5, 2021S
Recruiting
- Antibody-mediated Rejection
- Bortezomib
- Tehran, Iran, Islamic Republic ofSBMU
2020-12-30
Dec 30, 2020P
Recruiting
- Amyloidosis; Systemic
- Daratumumab
- +2 more
- Beijing, ChinaPeking Union Medical College Hospital
2021-05-31
May 31, 2021M
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Bortezomib
- +2 more
- Rochester, MinnesotaMayo Clinic in Rochester
2021-10-06
Oct 6, 2021H
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +2 more
- Bortezomib
- Mexico City, MexicoHospital General de México "Dr. Eduardo Liceaga"
2021-11-16
Nov 16, 2021E
Completed
- Multiple Myeloma
- Bortezomib
- +3 more
- Atlanta, GeorgiaEmory University Winship Cancer Institute
2021-11-01
Nov 1, 2021H
Recruiting
- Hematological Malignancy
- Bortezomib
- Detroit, MichiganHenry Ford hospital
2020-11-03
Nov 3, 2020D
Terminated
- Waldenstrom's Macroglobulinemia
- Everolimus
- +2 more
- Boston, MassachusettsDana-Farber Cancer Institute
2021-04-22
Apr 22, 2021J
Completed
- Acute Myelogenous Leukemia
- Bortezomib
- Doxil
- Sacramento, CaliforniaUniversity of California Comprehensive Cancer Center
2021-02-04
Feb 4, 2021S
Completed
- Multiple Myeloma
- Bortezomib
- +2 more
- Westwood, KansasThe University of Kansas Medical Center
2021-05-24
May 24, 2021A
Completed
- Chronic Antibody-mediated Transplant Rejection
- Bortezomib
- Plasma exchanges and intravenous immunoglobulins
- Paris, FranceHopital Necker Enfants-malades
2020-09-14
Sep 14, 2020P
Recruiting
- Multiple Myeloma
- Myeloma
- Isatuximab
- +3 more
- Poitiers, FranceCHU Poitiers
2021-11-03
Nov 3, 2021U
Recruiting
- Hodgkin's Lymphoma
- Lymphoma, Non-Hodgkin
- Bortezomib
- Ruxolitinib
- Ann Arbor, MichiganUniversity of Michgan Comprehensive Cancer Center
2021-02-10
Feb 10, 2021S
Active, not recruiting
- Diffuse Large B Cell Lymphoma
- Bortezomib
- Seoul, Korea, Republic ofSamsung Medical Center
2020-10-21
Oct 21, 2020N
Completed
- Chronic Myeloid Leukemia (CML)
- +4 more
- Bortezomib
- NK cells
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2021-11-11
Nov 11, 2021N
Recruiting
- GVHD
- Bortezomib
- Cyclophosphamide
- New York, New YorkNew York University School of Medicine
2021-04-20
Apr 20, 2021D
Completed
- Waldenstrom's Macroglobulinemia
- Bortezomib
- Rituximab
- Boston, MassachusettsDana-Farber Cancer Institute
2020-10-06
Oct 6, 2020J
Completed
- Kidney Cancer
- bortezomib
- Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
2020-08-17
Aug 17, 2020B
Completed
- Amyloidosis
- Bortezomib
- +2 more
- Boston, MassachusettsBoston Medical Center
2020-09-04
Sep 4, 2020M
Active, not recruiting
- Solid Tumor
- Urethral Cancer
- Bortezomib
- +2 more
- Houston, TexasUniversity of Texas MD Anderson Cancer Center
2020-12-01
Dec 1, 2020